Welcome to the InfoSci Platform
Targeted Nanotherapies for Diabetic Complications

Targeted Nanotherapies for Diabetic Complications

Pranav Kumar Prabhakar
Copyright: © 2024 |Pages: 23
ISBN13: 9798369304488|ISBN13 Softcover: 9798369304495|EISBN13: 9798369304501
DOI: 10.4018/979-8-3693-0448-8.ch006
Cite Chapter Cite Chapter

MLA

Prabhakar, Pranav Kumar. "Targeted Nanotherapies for Diabetic Complications." Cutting-Edge Applications of Nanomaterials in Biomedical Sciences, edited by Pranav Kumar Prabhakar and Ajit Prakash, IGI Global, 2024, pp. 178-200. https://doi.org/10.4018/979-8-3693-0448-8.ch006

APA

Prabhakar, P. K. (2024). Targeted Nanotherapies for Diabetic Complications. In P. Prabhakar & A. Prakash (Eds.), Cutting-Edge Applications of Nanomaterials in Biomedical Sciences (pp. 178-200). IGI Global. https://doi.org/10.4018/979-8-3693-0448-8.ch006

Chicago

Prabhakar, Pranav Kumar. "Targeted Nanotherapies for Diabetic Complications." In Cutting-Edge Applications of Nanomaterials in Biomedical Sciences, edited by Pranav Kumar Prabhakar and Ajit Prakash, 178-200. Hershey, PA: IGI Global, 2024. https://doi.org/10.4018/979-8-3693-0448-8.ch006

Export Reference

Mendeley
Favorite

Abstract

Diabetes mellitus is a chronic metabolic disorder characterized by impaired glucose regulation, which leads to various complications affecting multiple organs and systems. This chapter discusses various types of nanomaterials, such as liposomes, polymeric nanoparticles, dendrimers, and carbon-based nanomaterials, and their potential for encapsulating and delivering therapeutic agents to specific sites affected by diabetic complications. The advantages of nanomaterial-based drug delivery, including enhanced drug stability, prolonged circulation time, and improved targeting efficiency, are highlighted. The challenges and considerations associated with targeted nanotherapy development, including biocompatibility, toxicity, and regulatory aspects, are also discussed. The chapter serves as a valuable resource for researchers, clinicians, and healthcare professionals involved in the development and translation of targeted nano therapies, ultimately contributing to the advancement of diabetic complication management.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.